NASDAQ · USPH
Healthcare · Medical - Care Facilities
$78.21
Down-$0.27 (-0.34%)
Updated Aug 19, 2026, 6:00 AM
SID Score
5.4/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance
1M range · 21 trading sessions · Daily adjusted prices
USPH closed at $78.21 after 21 trading sessions, up 4.64% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 18, 2026 | $79.69 | $80.52 | $78.17 | $78.21 | 132.82K |
| Aug 17, 2026 | $81.22 | $81.22 | $77.53 | $78.48 | 205.42K |
| Aug 14, 2026 | $81.80 | $81.80 | $78.63 | $81.24 | 364.06K |
| Aug 13, 2026 | $82.99 | $83.43 | $82.08 | $82.76 | 176.68K |
| Aug 12, 2026 | $80.78 | $82.12 | $80.13 | $81.95 | 127.48K |
| Aug 11, 2026 | $81.45 | $83.07 | $80.52 | $81.67 | 179.76K |
| Aug 10, 2026 | $79.45 | $81.93 | $78.3912 | $81.74 | 200.23K |
| Aug 7, 2026 | $76.56 | $80.61 | $76.56 | $80.05 | 272.03K |
| Aug 6, 2026 | $75.58 | $77.28 | $70.64 | $76.46 | 450.25K |
| Aug 5, 2026 | $76.13 | $77.74 | $74.81 | $77.71 | 266.68K |
| Aug 4, 2026 | $77.31 | $78.515 | $75.84 | $75.86 | 242.64K |
| Aug 3, 2026 | $80.61 | $82.00 | $77.55 | $77.81 | 262.45K |
| Jul 31, 2026 | $80.03 | $80.64 | $77.02 | $79.06 | 437.29K |
| Jul 30, 2026 | $80.53 | $80.73 | $78.17 | $80.13 | 323.59K |
| Jul 29, 2026 | $78.88 | $80.75 | $77.185 | $79.85 | 419.44K |
| Jul 28, 2026 | $77.29 | $79.65 | $74.94 | $79.00 | 205.58K |
| Jul 27, 2026 | $75.07 | $76.65 | $73.25 | $76.64 | 156.67K |
| Jul 24, 2026 | $73.53 | $75.86 | $73.53 | $74.58 | 178.65K |
| Jul 23, 2026 | $73.98 | $75.56 | $72.48 | $72.97 | 343.65K |
| Jul 22, 2026 | $74.60 | $75.155 | $72.82 | $74.38 | 197.21K |
| Jul 21, 2026 | $73.87 | $76.59 | $73.87 | $74.74 | 166.81K |
The latest Smart Investors Daily articles mentioning USPH.
USPH research
Company profile and research snapshot.
US Physical Therapy Inc through its subsidiaries operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. The principal payment sources for the clinics' services are managed care programs, commercial health insurance, Medicare/Medicaid, workers' compensation insurance, and proceeds from personal injury cases. Its operating segment includes Physical therapy operations and Industrial injury prevention services. The company generates maximum revenue from the Physical therapy operations segment.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Aug 10, 2026 | Barrington Research | Outperform | — |
| Jun 24, 2026 | Citizens | Market Outperform | — |
| May 13, 2026 | Barrington Research | Outperform | — |
| May 8, 2026 | Citizens | Market Outperform | — |
| Feb 20, 2026 | Barrington Research | Outperform | — |
No generated briefing is available yet.
Benzinga · Aug 10, 2026
Barrington Research analyst Michael Petusky maintains US Physical Therapy (NYSE:USPH) with a Outperform and raises the price target from $90 to $98.
SeekingAlpha · Aug 7, 2026
U.S. Physical Therapy, Inc.
SeekingAlpha · Aug 6, 2026
U.S. Physical Therapy, Inc. stock analysis: Q2 2026 revenue beat but EPS miss, rising costs, and premium valuation. Click for this USPH earnings update.
ChartMill · Aug 6, 2026
US Physical Therapy Q2 revenue meets expectations, but EPS misses; management reaffirms FY guidance, citing stronger H2 with hospital integrations.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning USPH.
